Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Skyclarys

PharmaCompass

01

Brand Name : Skyclarys

Omaveloxolone

arrow
APS Symposium
Not Confirmed

Brand Name : Skyclarys

arrow
APS Symposium
Not Confirmed

Omaveloxolone

Main Therapeutic Indication : Rare Diseases

Currency : USD

2023 Revenue in Millions : 56

2022 Revenue in Millions : 0

Growth (%) : New Launch

blank

02

Brand Name : Skyclarys

Omaveloxolone

arrow
APS Symposium
Not Confirmed

Brand Name : Skyclarys

arrow
APS Symposium
Not Confirmed

Omaveloxolone

Main Therapeutic Indication : Rare Diseases and Disorders

Currency : USD

2024 Revenue in Millions : 383

2023 Revenue in Millions : 56

Growth (%) : 584

blank